Sergio Marullo di Condojanni

Sergio Marullo di Condojanni

Director/Board Member at TAMBURI INVESTMENT PARTNERS S.P.A.
48 year
Finance
Health Technology
Consumer Services

Profile

Sergio Marullo di Condojanni is Chief Executive Officer at Angelini Pharma SpA since 2026, Chief Executive Officer at Angelini Industries since 2020, Chief Executive Officer at Angelini Finanziaria SpA since 2017, Chief Executive Officer & Director at Angelini Holding SpA since 2020, Independent Director at Tamburi Investment Partners SpA since 2022, Director at Bambino Gesu Hospital since 2023, and Director at Catalyst Pharmaceuticals, Inc. since 2026.
Formerly, Dr. di Condojanni was Director at Banca Aletti SpA from 2018 to 2022.
Education includes a doctorate conferred in 2007 and a graduate degree from The LUISS University of Rome.

Sergio Marullo di Condojanni active positions

CompaniesPositionStart
TAMBURI INVESTMENT PARTNERS S.P.A. Director/Board Member 2021-12-31
CATALYST PHARMACEUTICALS, INC. Director/Board Member 2026-07-14
Chief Executive Officer 2020-06-30
Chief Executive Officer 2016-12-31
Bambino Gesu Hospital
Director/Board Member 2023-09-30
Chief Executive Officer 2026-01-20

Former positions of Sergio Marullo di Condojanni

CompaniesPositionEnd
Director/Board Member 2021-12-31
See the detail of Sergio Marullo di Condojanni's experience

Training of Sergio Marullo di Condojanni

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Finance

Finance

Consumer Services

Miscellaneous

Bambino Gesu Hospital

Finance

Health Technology

  1. Stock Market
  2. Insiders
  3. Sergio Marullo di Condojanni